Coriolis

Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings

Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring. Coriolis is now preparing for inspection by the competent surveillance authority for the confirmation to perform AUC services in compliance with GMP. The first clients have already started their projects. 6 March 2024 -- Martinsried-Munich, Germany --...

Coriolis Pharma and U-Medico Announce a Strategic Alliance

MARTINSRIED, Germany and OSAKA, Japan, March 17, 2022 / B3C newswire / -- Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs located in Germany, and U-Medico, an innovative formulation development and biophysical characterisations service provider located in Japan, today announce a strategic...
Fraunhoferstraße 18 b 82152, Martinsried

+49 89 41 77 60 – 0